Researcher
Nick Geukens
- Disciplines:Laboratory medicine, Medical biotechnology, Regenerative medicine, Other basic sciences, Other health sciences, Drug discovery and development, Pharmaceutics, Other medical and health sciences
Affiliations
- Therapeutic and Diagnostic Antibodies (Division)
Member
From15 May 2019 → Today - Chemistry, Kulak Kortrijk Campus (Department)
Member
From1 Sep 2009 → 14 May 2019 - Faculty of Science, Kulak Kortrijk Campus (Faculty)
Member
From14 Jul 2008 → 31 Aug 2009 - Laboratory of Molecular Bacteriology (Rega Institute) (Division)
Member
From1 Oct 1999 → 13 Jul 2008
Projects
11 - 20 of 23
- Development and streamlining a validation and implementation workflow for model-informed precision dosing for biologicals and antimicrobialsFrom1 Oct 2020 → 30 Sep 2022Funding: IOF - technology validation in lab
- Towards a rapid diagnostic test for thrombotic thrombocytopenic purpuraFrom30 Oct 2018 → 31 Oct 2021Funding: FWO Strategic Basic Research Grant
- Autoantibodies in autoimmune-mediated thrombotic thrombocytopenic purpura: from mechanistic insights towards the first steps in targeted therapyFrom1 Oct 2018 → 30 Sep 2020Funding: BOF - Bilateral scientific cooperation
- Bleeding after left ventricular assist device implantation in heart patients: a novel therapyFrom1 Oct 2017 → 30 Sep 2019Funding: IOF - Industrial Research Fund
- Mouse housing and micorscopy platform for cardiovascular and antibody-based researchFrom1 Oct 2016 → 30 Sep 2018Funding: Fund Recuperation Fiscal Exemption
- Novel biosensing concepts for advancing antigen-specific antibody detectionFrom15 Jul 2016 → 20 Apr 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- Towards a novel therapy to treat bleeding after left ventricular assist device implantation in patients with heart failure.From1 Jan 2016 → 22 Feb 2021Funding: FWO Strategic Basic Research Grant
- Alzheimers disease: towards innovative diagnostics and disease-modifying therapeutics.From1 Oct 2015 → 30 Sep 2017Funding: IOF - Industrial Research Fund
- Exploration of nanoparticle-sized immunobeads for isolation and quantitative detection of human pathogenic free-living amoebae in complex water systems.From1 Jan 2011 → 31 Dec 2014Funding: FWO research project (including WEAVE projects)
- Synthesis of functional nanoparticles for the quantification of aquatic pathogenic micro-organisms.From1 Oct 2010 → 31 Dec 2015Funding: IWT personal funding - strategic basic research grants
Publications
1 - 10 of 65
- Exploring the Fate of Antibody-Encoding pDNA after Intramuscular Electroporation in Mice(2023)
Authors: Marie-Lynn Cuypers, Nick Geukens, Paul Declerck, Maarten Dewilde
- Antinuclear antibodies in individuals with COVID-19 reflect underlying disease: Identification of new autoantibodies in systemic sclerosis (CDK9) and malignancy (RNF20, RCC1, TRIP13)(2023)
Authors: Xavier Bossuyt, Glynis Frans, Nick Geukens, Sebastien Carpentier, Sabine Tejpar, Hans Wildiers, Daniel Engelbert Blockmans, Ellen De Langhe, Pieter Vermeersch, Rita Derua
- FLUIDOT: a Modular Microfluidic Platform for Single-Cell Study and Retrieval, with Applications in Drug Tolerance Screening and Antibody Mining(2023)
Authors: Jolien Breukers, Karen Ven, Iene Rutten, Maya Imbrechts, Julie Van Lent, Winnie Kerstens, Sam Noppen, Dominique Schols, Hendrik Jan Thibaut, Karen Vanhoorelbeke, et al.
- Complementarity determining regions in SARS-CoV-2 hybrid immunity(2023)
Authors: Glynis Frans, Jonas De Leeuw, Wim Maes, Bas Calcoen, Nick Geukens, Rita Derua, Pieter Vermeersch, Sebastien Carpentier, Xavier Bossuyt
- Detection of Breast Cancer-Specific Extracellular Vesicles with Fiber-Optic SPR Biosensor(2023)
Authors: Yagmur Yildizhan, Debby Thomas, Nick Geukens, Jeroen Lammertyn, Dragana Spasic
- Bivalent intra-spike binding provides durability against emergent Omicron lineages Results from a global consortium(2023)
Authors: Nick Geukens, Maya Imbrechts
- Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model(2022)
Authors: Debby Thomas, Maarten Dewilde, Nick Geukens, Paul Declerck
- Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model(2022)
Authors: Maya Imbrechts, Wim Maes, Louanne Ampofo, Nathalie Van den Berghe, Bas Calcoen, Winnie Kerstens, Madina Rasulova, Sam Noppen, Rana Abdelnabi, Piet Maes, et al.
- Next generation point-of-care test for therapeutic drug monitoring of adalimumab in patients diagnosed with autoimmune diseases(2022)
Authors: Henry Ordutowski, Francesco Dal Dosso, Wout De Wispelaere, Charlotte Van Tricht, Séverine Vermeire, Nick Geukens, Dragana Spasic, Jeroen Lammertyn
- Intratumoral DNA-based delivery of checkpoint-inhibiting antibodies and interleukin 12 triggers T cell infiltration and anti-tumor response(2022)
Authors: Liesl Jacobs, Lidia Yshii, Steffie Junius, Nick Geukens, Adrian Liston, Paul Declerck
Pages: 984 - 992
Patents
1 - 5 of 5
- Screening and sorting of single cells (Inventor)
- Dual targeting of tafi and pai-1 (Inventor)
- Screening and sorting of single cells (Inventor)
- Dual targeting of tafi and pai-1 (Inventor)
- Dual targeting of tafi and pai-1 (Inventor)